Summary
Millions of Americans suffer from depression and anxiety. The exact causes of these conditions are not definitively known, but they can be treated effectively with medication, counseling, and other methods. Because the severity of these illnesses varies and individuals react to medications differently, pharmaceutical companies have developed many different drugs for these conditions. These medications affect a variety of biochemical pathways and areas of the brain and are typically used in conjunction with counseling and therapy. Newly updated, Antidepressants and Antianxiety Drugs, Third Edition explores the benefits and drawbacks to these drugs.
About the Author(s)
Alan I. Hecht, DC, is a practicing chiropractor in New York. He is also an adjunct professor at Farmingdale State College, the C.W. Post campus of Long Island University, and Nassau Community College. He teaches courses in medical microbiology, anatomy and physiology, comparative anatomy, human physiology, human nutrition, and embryology. In addition, he is a professor of anatomy and physiology and professor of microbiology at Hofstra University, where he is an adjunct associate professor. He is also course coordinator for graduate anatomy and physiology for medical physics at the Donald and Barbara Zucker School of Medicine at Hofstra/Northwell.
Dr. Hecht received his BS in biology–pre-medical studies from Fairleigh Dickinson University in Teaneck, New Jersey. He received his MS in basic medical sciences from New York University School of Medicine. He also received his Doctor of Chiropractic (DC) degree from New York Chiropractic College in Brookville, New York. Dr. Hecht is the recipient of the Chancellors' Award for Excellence in Adjunct Teaching from the State University of New York.